Abstract
Many stomach and oesophageal cancers are advanced when they are diagnosed making the treatment palliative and the prognosis poor. The effective relief of symptoms that restrict enjoyment of the physical, psychological and social elements of life, such as eating and drinking is paramount. Nevertheless, research into the causes and treatment of this significant cause of cancer morbidity and mortality continues and a recent report on the addition of a regimen of perioperative chemotherapy before and after surgery for localized respectable gastric cancer was found to significantly improve survival compared with surgery alone. The researchers report on results from the UK Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial may be in the July 6 issue of the New England Journal of Medicine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
